Evidence map›Paper›PMID 39373788›Full record

ArticleJournal of clinical immunology2024

Granulomas in Common Variable Immunodeficiency Display Different Histopathological Features Compared to Other Granulomatous Diseases.

Astrid C van Stigt, Jan H von der Thüsen, Dana A M Mustafa, Thierry P P van den Bosch, Karishma A Lila, Disha Vadgama, Martin van Hagen, Virgil A S H Dalm, Willem A Dik, Hanna IJspeert

Abstract readComparative Study
In one paragraph

Article in Journal of clinical immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Review
  4. What's the connection? Sarcoidosis and combined variable immunodeficiency: A Single center retrospective case series.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Astrid C van StigtErasmus Medical Center, Laboratory of Medical Immunology, Department of Immunology, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Jan H von der ThüsenDepartment of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Dana A M MustafaDepartment of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Thierry P P van den BoschDepartment of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Karishma A LilaDepartment of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Disha VadgamaDepartment of Pathology and Clinical Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Martin van HagenErasmus Medical Center, Laboratory of Medical Immunology, Department of Immunology, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Virgil A S H DalmErasmus Medical Center, Laboratory of Medical Immunology, Department of Immunology, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Willem A DikErasmus Medical Center, Laboratory of Medical Immunology, Department of Immunology, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Hanna IJspeertErasmus Medical Center, Laboratory of Medical Immunology, Department of Immunology, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands. h.ijspeert@erasmusmc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Granulomatous disease affects up to 20% of patients with Common Variable Immunodeficiency (CVID). Granulomas are comprised of highly activated immune cells, and emerge in response to antigenic triggers. In CVID granulomas however, the underlying pathophysiology is unclear and the specific trigger remains unknown. Granuloma formation in CVID is often compared to sarcoidosis, although clinical context and prognosis differ, suggesting a different pathogenesis. The aim of this study was to investigate if the cellular organization and proteomics of granulomas in CVID is different from other granulomatous diseases. Therefore, tissue slides from formaldehyde fixed paraffin embedded biopsies obtained from patients with CVID, sarcoidosis, tuberculosis and foreign-material induced pseudo-sarcoidosis were stained with hematoxylin and eosin and assessed for histopathological characteristics. Targeted spatial protein analysis was performed, and immune fluorescent multiplex assays were used to analyze the cellular organization. Histological analysis revealed that CVID granulomas were smaller, less circumscribed, with fewer multinucleated giant cells and minimal fibrosis compared to the other granulomatous diseases. Spatial protein analysis showed that granulomas in all diseases expressed CD68, CD11c, CD44, CD127, and PD-L1. However in CVID, reduced expression of the fibrosis-related protein fibronectin, but enrichment of CD163, CD3 and FAPα inside CVID granulomas was observed. Immunofluorescence analysis conformed a different cellular organization in CVID granulomas with increased influx of neutrophils, macrophages, T and B lymphocytes. In conclusion, granulomas in CVID display a different histological and cellular organization with increased influx of myeloid and lymphoid cells, compared to sarcoidosis, tuberculosis and pseudo-sarcoidosis, indicating a distinct pathogenesis underlying granuloma formation.

Indexed as

Common Variable ImmunodeficiencyGranulomaAdultAgedBiopsyFemaleHumansMaleMiddle AgedProteomicsSarcoidosisYoung AdultCommon variable immunodeficiencyGranulomaHistologySarcoidosisSpatial protein expression

Identifiers

PMID39373788
PMCPMC11458708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.